JW Therapeutics Presents Latest Data of Carteyva® at 2022 ASCO Annual Meeting

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Related Keywords

China ,Shanghai ,United States ,Hong Kong ,Chinese ,American ,A Bristol Myers Squibb ,National Significant New Drug Development Program ,China National Medical Products Administration ,American Society Of Clinical Oncology ,Clearing Limited Hkex ,Clinical Oncology ,Annual Meeting ,Relmacabtagene Autoleucel Injection ,Juno Therapeutics ,Bristol Myers Squibb ,Hong Kong Exchanges ,Clearing Limited ,Health ,Pr Newswire ,Non Hodgkin Lymphoma ,Lymphoma ,